Importantly, patients with elevated SATB1 levels have significantly shorter survival times than those with lower SATB1 expression, making SATB1 a predictive marker for recurrence and poor prognosis in ESCC (120, 121). This evidence concerns the gene SATB1 and esophageal squamous cell carcinoma.